{"product_id":"biolegend-302702","title":"Biolegend, 302702, Purified anti-human CD26 Antibody, 100μg","description":"\u003cp\u003eCD26 is a 110 kD type II membrane protein also known as ADA-binding protein and dipeptidyl peptidase IV (DPPIV). It is a member of the peptidase and ectoenzyme family. CD26 is expressed on the membrane of mature thymocytes, T lymphocytes (upregulated upon activation), B cells, NK cells, and macrophages. CD26 cleaves off N-terminal X-Pro and X-Ala dipeptides from polypeptides. It plays an integral role as a costimulatory molecule in T cell activation. CD26 may interact with extracellular matrix proteins such as fibronectin or collagen, CD45 and ADA.\u003cbr\u003e\n100μg\u003cbr\u003e\nVerified Reactivity: Human\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Mouse\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography.\u003cbr\u003e\nConcentration: 0.5 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Kishimoto T, et al. Eds. 1997. Leucocyte Typing VI. Garland Press. London. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.\u003cbr\u003e\nProduct Citations: Alcántara‐Hernández M et al. 2017. Immunity. 47(6):1037-1050 . PubMed van der Heide V, et al. 2022. Cell Rep. :110508. PubMed Liu S, et al. 2021. Cell Rep Med. 2:100411. PubMed O'Boyle KC, et al. 2020. Methods Mol Biol. 2111:1. PubMed Henrick BM, et al. 2021. Cell. . PubMed Bengsch B et al. 2018. Immunity. 48(5):1029-1045 . PubMed Sander J et al. 2017. Immunity. 47(6):1051-1066 . PubMed Dutertre CA, et al. 2020. Immunity. 51(3):573-589.e8.. PubMed\u003cbr\u003e\nRRID: AB_314286 (BioLegend Cat. No. 302702)\u003cbr\u003e\nStructure: Peptidases and ectoenzyme families, type II glycoprotein, 110 kD\u003cbr\u003e\nDistribution: Thymocyte subset, memory T cells, B cells, NK cells, epithelial cells, macrophages\u003cbr\u003e\nFunction: Dipeptidyl peptidase, T cell costimulation, HIV entry\u003cbr\u003e\nLigand\/Receptor: Adenosine-deaminase, collagen\u003cbr\u003e\nCell Type: B cells, Epithelial cells, Macrophages, NK cells, T cells, Thymocytes\u003cbr\u003e\nBiology Area: Costimulatory Molecules, Immunology\u003cbr\u003e\nMolecular Family: CD Molecules\u003cbr\u003e\nAntigen References: 1. Kameoka J, et al. 1993. Science 261:466. 2. Dang N, et al. 1990. J. Exp. Med. 172:649.\u003cbr\u003e\nGene ID: 1803\u003cbr\u003e\nUniProt: View information about CD26 on UniProt.org\u003cbr\u003e\nClone: BA5b\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nWorkshop: VI N-L078\u003cbr\u003e\nOther Names: ADA-binding protein, DPP IV ectoenzyme, EC 3.4.14.5, DPP4\u003cbr\u003e\nIsotype: Mouse IgG2a, κ\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46862899740841,"sku":"302702","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/es\/products\/biolegend-302702","provider":"Iright","version":"1.0","type":"link"}